Searched for
DUSA
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...- Sun Pharma arm settles case with Biofrontera, to get USD 22.5 mnIn 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience Gmb...
- Sun Pharma arm resolves product promotion investigation with US justice department"DUSA fully cooperated with DOJ in its investigation of a complaint filed by a former employee in September 2016,” Sun Pharmaceutical Indus...
- Sun Pharma gains 2% on winning patent infringement caseThe pharma giant made the announcement post markets hours of Wednesday.
- Sun Pharma arm gets relief from US court in patent infringement caseThe lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.
- Sun Pharma's subsidiary files patent infringement suit against German drug maker BiofronteraDUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained co...
- US secures airbase in Romania, begins pull out from KyrgyzstanUS will use a Romanian airbase as a transit point for its troops leaving Afghanistan as it winds up operations at another base in Kyrgyzsta...
- Sun Pharma in talks to buy Sweden's Meda AB for up to $5 billion: ReportsSun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to $5 billion, according to med...
- Sun Pharma is doing great but US Arm Taro may be peakingTaro's Q4 revenue fell sequentially, while local business continued to outperform industry.
- Hot stock: Morgan Stanley sees more upside in Sun PharmaMS has maintained 'Overweight' rating on Sun Pharma and added the stock to “Asia Best Idea”.
- Sun Pharma continues its growth momentum in the December QuarterThe company logged 33% growth in its consolidated net sales and its operating profit margin stood at 44%.
- Sun Pharma Q3 net profit at Rs 881.30 croreSun Pharma today reported a consolidated net profit of Rs 881.30 crore for the third quarter ended December 31, 2012.
- Sun Pharma's US-based subsidiary Caraco completes tender offer to acquire Dusa PharmaDrug firm Sun Pharmaceutical Industries today said its US-based subsidiary Caraco has successfully completed the tender offer to acquire Du...
- Sun Pharma: Strategic acquisitions to give drug firm a shot in the armGiven its past track record, investors can trust the company to go for strategically important acquisitions in its key markets.
- What Does Sun Pharma's September Quarter Performance Indicate?With Caraco resuming manufacturing at its facilities in Michigan, the company is likely to gradually recover any loss in revenues.
- Looking for larger acquisitions in key markets: Sun PharmaSun Pharmaceutical Industries today said it is looking forward to larger acquisitions as a part of its expansion plans.
- Sun Pharmaceuticals to buy US-based DUSA for $230 million; stock gainsShares of Sun Pharma moved higher in trade of Friday as sentiment turned bullish after it signed a pact to buy US-based DUSA Pharmaceutical...
- Sun Pharma to buy US-based DUSA Pharmaceuticals for $230 millionUnder the terms of agreement, a 100% subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a pr...
- Sun Pharma to acquire US dermatology company DUSA PharmaSun Pharma is to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminole...
- India Inc on shopping spree, announces deals worth Rs 2,850 croreIn major deals worth Rs 2,850 crore, homegrown companies today announced acquisitions of assets from global firms with Sun Pharma buying DU...
Load More
